Duracef en es it fr

Duracef Brand names, Duracef Analogs

Duracef Brand Names Mixture

  • None

Duracef Chemical_Formula


Duracef RX_link


Duracef fda sheet

Duracef msds (material safety sheet)

Duracef Synthesis Reference

L. B. Crast, Jr., U.S. Pat. 3,489,752 (1969)

Duracef Molecular Weight

363.389 g/mol

Duracef Melting Point


Duracef H2O Solubility

1110 mg/L

Duracef State


Duracef LogP


Duracef Dosage Forms

Capsule; Tablet; Oral liquid

Duracef Indication

For the treatment of the following infections (skin, UTI, ENT) caused by; S. pneumoniae, H. influenzae, staphylococci, S. pyogenes (group A beta-hemolytic streptococci), E. coli, P. mirabilis, Klebsiella sp, coagulase-negative staphylococci and Streptococcus pyogenes

Duracef Pharmacology

Cefadroxil, a first-generation cephalosporin antibiotic, is used to treat urinary tract infections, skin and skin structure infections, pharyngitis, and tonsillitis.

Duracef Absorption

Cefadroxil is well absorbed on oral administration; food does not interfere with its absorption.

Duracef side effects and Toxicity

Nausea, vomiting, diarrhoea, allergic rashes may occur

Duracef Patient Information

Patients should be counseled that intibacterial drugs including DURICEF should only be used to treat bacterial infections. They do not treat viral infections (eg. the common cold). When DURICEF is prescribed to treat a bacterial infection, patients should be told that although it is common to feel better early in the course of therapy, the medication should be taken exactly as directed. Skipping doses or not completing the full course of therapy may (1) decrease the effectiveness of the immediate treatment and (2) increase the likelyhood that bacteria will develop resistance and will not be treatable by DURICEF or other antibacterial drugs in the future.

Duracef Organisms Affected

Enteric bacteria and other eubacteria